SNGX
Price
$0.36
Change
-$0.01 (-2.70%)
Updated
Sep 11 closing price
Capitalization
7.95M
55 days until earnings call
Intraday BUY SELL Signals
VBIO
Price
$2.26
Change
+$0.06 (+2.73%)
Updated
Sep 11 closing price
Capitalization
2.01M
Intraday BUY SELL Signals
Interact to see
Advertisement

SNGX vs VBIO

SNGX vs VBIO Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
SNGX vs. VBIO commentary
Sep 13, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SNGX is a Hold and VBIO is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SNGX($7.95M) has a higher market cap than VBIO($2.01M). SNGX YTD gains are higher at: -72.836 vs. VBIO (-93.766). SNGX has higher annual earnings (EBITDA): -11.04M vs. VBIO (-15.95M). SNGX has more cash in the bank: 9.81M vs. VBIO (2.11M). SNGX has less debt than VBIO: SNGX (303K) vs VBIO (17.4M). SNGX (0) and VBIO (0) have equivalent revenues.
SNGXVBIOSNGX / VBIO
Capitalization7.95M2.01M396%
EBITDA-11.04M-15.95M69%
Gain YTD-72.836-93.76678%
P/E RatioN/AN/A-
Revenue00-
Total Cash9.81M2.11M465%
Total Debt303K17.4M2%
FUNDAMENTALS RATINGS
SNGX vs VBIO: Fundamental Ratings
SNGX
VBIO
OUTLOOK RATING
1..100
8694
VALUATION
overvalued / fair valued / undervalued
1..100
14
Undervalued
81
Overvalued
PROFIT vs RISK RATING
1..100
10098
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
8698
P/E GROWTH RATING
1..100
10070
SEASONALITY SCORE
1..100
18n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SNGX's Valuation (14) in the Biotechnology industry is significantly better than the same rating for VBIO (81) in the null industry. This means that SNGX’s stock grew significantly faster than VBIO’s over the last 12 months.

VBIO's Profit vs Risk Rating (98) in the null industry is in the same range as SNGX (100) in the Biotechnology industry. This means that VBIO’s stock grew similarly to SNGX’s over the last 12 months.

VBIO's SMR Rating (100) in the null industry is in the same range as SNGX (100) in the Biotechnology industry. This means that VBIO’s stock grew similarly to SNGX’s over the last 12 months.

SNGX's Price Growth Rating (86) in the Biotechnology industry is in the same range as VBIO (98) in the null industry. This means that SNGX’s stock grew similarly to VBIO’s over the last 12 months.

VBIO's P/E Growth Rating (70) in the null industry is in the same range as SNGX (100) in the Biotechnology industry. This means that VBIO’s stock grew similarly to SNGX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
SNGXVBIO
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
83%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 10 days ago
70%
Bullish Trend 20 days ago
86%
Declines
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 5 days ago
90%
COMPARISON
Comparison
Sep 13, 2026
Stock price -- (SNGX: $0.36 vs. VBIO: $2.26)
Brand notoriety: SNGX and VBIO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: SNGX: 55% vs. VBIO: 38%
Market capitalization -- SNGX: $7.95M vs. VBIO: $2.01M
SNGX [@Biotechnology] is valued at $7.95M. VBIO’s [@Biotechnology] market capitalization is $2.01M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $130.64B. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SNGX’s FA Score shows that 1 FA rating(s) are green while VBIO’s FA Score has 0 green FA rating(s).

  • SNGX’s FA Score: 1 green, 4 red.
  • VBIO’s FA Score: 0 green, 5 red.
According to our system of comparison, SNGX is a better buy in the long-term than VBIO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SNGX’s TA Score shows that 3 TA indicator(s) are bullish while VBIO’s TA Score has 2 bullish TA indicator(s).

  • SNGX’s TA Score: 3 bullish, 6 bearish.
  • VBIO’s TA Score: 2 bullish, 8 bearish.
According to our system of comparison, SNGX is a better buy in the short-term than VBIO.

Price Growth

SNGX (@Biotechnology) experienced а -4.66% price change this week, while VBIO (@Biotechnology) price change was -18.41% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.09%. For the same industry, the average monthly price growth was -3.45%, and the average quarterly price growth was +2531.70%.

Reported Earning Dates

SNGX is expected to report earnings on Nov 06, 2026.

Industries' Descriptions

@Biotechnology (-6.09% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
SNGX
Daily Signal:
Gain/Loss:
VBIO
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TSAT49.752.61
+5.54%
Telesat Corp
CLAR3.55N/A
N/A
Clarus Corp
IRTC111.43-1.45
-1.28%
iRhythm Holdings Inc.
AWK137.69-2.15
-1.54%
American Water Works Company
GELS0.70-0.09
-11.05%
Gelteq Ltd

SNGX and

Correlation & Price change

A.I.dvisor indicates that over the last year, SNGX has been loosely correlated with ERAS. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if SNGX jumps, then ERAS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNGX
1D Price
Change %
SNGX100%
-0.79%
ERAS - SNGX
50%
Loosely correlated
-0.94%
CNTN - SNGX
46%
Loosely correlated
-1.86%
QURE - SNGX
36%
Loosely correlated
+0.09%
LGVN - SNGX
34%
Loosely correlated
+10.39%
DCOY - SNGX
32%
Poorly correlated
-1.47%
More

VBIO and

Correlation & Price change

A.I.dvisor tells us that VBIO and SNGX have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that VBIO and SNGX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VBIO
1D Price
Change %
VBIO100%
+2.73%
SNGX - VBIO
26%
Poorly correlated
-0.79%
ATOS - VBIO
25%
Poorly correlated
+7.26%
DARE - VBIO
25%
Poorly correlated
+0.13%
ENLV - VBIO
23%
Poorly correlated
-2.16%
BNTC - VBIO
23%
Poorly correlated
-0.25%
More